An official website of the State of Louisiana.
Official Louisiana State Websites use .la.gov A .la.gov website belongs to an official
Secure .gov websites use HTTPS A lock () or https:// means you've safely
Taking Aim at Cancer in Louisiana (TACL), an organization formed last year to address Louisiana’s high rates of cancer, reached a milestone last month when its executive committee adopted bylaws and elected officers to establish TACL (pronounced ‘tackle’) as a 501(c)(3) nonprofit corporation. The Louisiana Department of Health is currently providing leadership and support for the initiative.
Dr. Rebekah Gee, secretary of the Louisiana Department of Health, said that having three pharmaceutical companies submit a response means the State is one giant step closer to its goal of eliminating hepatitis C in Louisiana.
Because of the commitment of this administration, Louisiana now has an eligibility and enrollment system that is more robust than what had been in place for decades. The new system runs more frequent checks on information that drives eligibility decisions, including employment status and income. This means that as the economy improves and people's income increases, Medicaid is alerted and cases are closed, as appropriate.
February is American Heart Health Month and an important time to highlight the importance of efforts to improve heart health in Louisiana. Over the past year, the Louisiana Department of Health’s Well-Ahead Louisiana initiative within the Office of Public Health, in collaboration with other partners across the state, received technical assistance and guidance through a grant from the National Governors Association (NGA) to focus on improving heart health in Louisiana.
The Louisiana Department of Health is requesting proposals from managed care companies for the state’s Medicaid managed care program. The state’s current Medicaid-managed care contracts will expire on Dec. 31, 2019 with the new contracts procured through this RFP beginning January 2020.
The purpose of this Request for Proposals (RFP) is to obtain competitive proposals from qualified managed care organizations (MCOs) to provide high quality healthcare services statewide to Medicaid enrollees in the Louisiana Medicaid managed care program.
Louisiana was recognized this week by the federal Centers for Medicare & Medicaid Services (CMS) for implementing best practices aimed at eliminating waste, fraud and abuse in state Medicaid programs. Louisiana is one of only eight states to receive this honor.
The new online Public Records Request Portal gives users the opportunity to submit public records requests, track their records requests and view an archive of all publicly-accessed records.
Dr. Rebekah Gee, secretary of the Louisiana Department of Health, has been recognized by Modern Healthcare as one of its 2019 Women Leaders to Watch in Healthcare.
Flu season is reaching its peak in Louisiana, with flu activity spiking over the last week. Because of this, the Louisiana Department of Health is encouraging Louisianans to catch beads, and not the flu, this Mardi Gras season.
The Louisiana Department of Health (LDH), Medical Vendor Administration (MVA), Benefits and Services/Pharmacy Benefits Management Program is inviting qualified proposers to submit proposals for services to provide the expertise needed to assist the Department in developing, implementing, and providing continuing support to the State Supplemental Rebate/PDL and Drug Rebate Processing functions for the Medicaid Pharmacy Program in accordance with the specifications and conditions set forth in the RFP Document linked below.
The purpose of this Solicitation for Offers (SFO) is to obtain competitive Offers from qualified pharmaceutical manufacturers who are interested in providing a commitment to enter into contract negotiations that obligate the successful Manufacturer(s) to deliver at least: (a) an unrestricted supply of direct-acting antiviral (DAA) medications each year for the term of the resulting contract (b) at an annual cost not to exceed the Total State Spend on hepatitis C medications in the Medicaid population, estimated to be $30 million dollars, and the Total State Spend on hepatitis C medications in the Corrections population, estimated to be $5 million dollars, for State Fiscal Year 2018; and (c) any additional complementary services that such manufacturer(s) deem necessary and appropriate to promote the strategies of the Hepatitis C Statewide Elimination Program, reproduced below.